The Lind Partners

Red Cat Holdings is a military technology company focused on integrating robotic hardware and software to deliver critical situational awareness and actionable intelligence for military operations. The company aims to enhance the effectiveness and safety of warfighters and battlefield commanders both domestically and globally. Red Cat offers a diverse range of solutions, including Teal Drones, which develops the Golden Eagle, a small unmanned system designed for high-resolution imaging during nighttime operations. Additionally, Red Cat collaborates with Skypersonic, which provides unmanned aircraft capable of operating in challenging environments, such as interior spaces. Furthermore, Red Cat is working on a fully-integrated drone supply chain that incorporates secure blockchain-based distributed storage, analytics, and software-as-a-service solutions, facilitating broader adoption within the drone industry.

Fortune is currently focused on advancing the vertically integrated NICO cobalt-gold-bismuth-copper project, comprised of a proposed mine and mill in the Northwest Territories that will produce a bulk concentrate for shipment to a refinery that the Company plans to construct in Saskatchewan. The products that will be produced at the refinery include cobalt chemicals used to make high-performance rechargeable batteries, bismuth metals, and chemicals, as well as gold. It was founded in 1988 and is based in London, Ontario, Canada.

Fortune is currently focused on advancing the vertically integrated NICO cobalt-gold-bismuth-copper project, comprised of a proposed mine and mill in the Northwest Territories that will produce a bulk concentrate for shipment to a refinery that the Company plans to construct in Saskatchewan. The products that will be produced at the refinery include cobalt chemicals used to make high-performance rechargeable batteries, bismuth metals, and chemicals, as well as gold. It was founded in 1988 and is based in London, Ontario, Canada.

Know Labs, Inc. is a Seattle-based company focused on developing and marketing proprietary diagnostic technologies that utilize electromagnetic energy for analytics. Its key innovations, Bio-RFID and ChromaID, enable the identification, authentication, and diagnosis of both organic and inorganic materials. The company is working on a non-invasive glucose monitoring device, known as the UBAND, designed to provide real-time blood glucose readings for individuals with diabetes and pre-diabetes. Know Labs also operates through its subsidiary, TransTech Systems, Inc., which specializes in employee and personnel identification solutions. The company has established a research agreement with Mayo Clinic to validate its Bio-RFID technology. Originally founded in 1998 as Visualant, Incorporated, Know Labs rebranded in 2018 and has continued to advance its technology in the medical diagnostic field.

Ainos is a medical technology company that provides low-dose interferon drug solutions, AI-powered medical devices and preventive medicine.

PARTS iD, Inc. is a technology-driven, digital commerce company focused on creating custom infrastructure and unique user experiences within niche markets.

GSE Solutions, Inc. provides performance improvement solutions to the energy and process industries. They improve human performance through turnkey training, unique visualization and simulation applications, and our staff of instructors, as well as plant improvement through our engineering expertise and use of technology to improve plant design, commissioning, and operations.

PaxMedica Inc. is a clinical-stage biopharmaceutical company dedicated to developing anti-purinergic therapies (APT) for neurodevelopmental disorders. It primarily focuses on conditions such as autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company's lead candidate, PAX-101, is an intravenous formulation of suramin currently undergoing a Phase III clinical trial for Human African Trypanosomiasis, a Phase IIB trial for autism spectrum disorder, and is in preclinical stages for treating Fragile X syndrome tremor-ataxia. Additionally, PaxMedica is developing PAX-102, an intranasal formulation of suramin, which is in preclinical development for neurodevelopmental indications, along with early discovery programs aimed at selective antipurinergic therapies. Founded in 2018, the company is based in Woodcliff Lake, New Jersey.

Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets. It develops a plant-based non-soy alternative to dairy-based baby formula.

Bragg Gaming Group is a content-driven technology provider specializing in iGaming solutions for online and land-based gaming operators. The company develops proprietary casino gaming titles through its in-house studios, including Wild Streak Gaming, Spin Games, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. Its diverse portfolio features a wide array of gaming options such as slot games, table games, video bingo, scratch cards, virtual sports, and live dealer experiences. Bragg Gaming Group also aggregates content from select partner studios, enabling the distribution of games via its Bragg remote games server and the Bragg Hub content delivery platform. This platform allows for streamlined management through a single back-office system, enhanced by advanced data analytics tools and a player engagement suite known as Fuze. The company primarily generates revenue from the Netherlands and Curacao, positioning itself as a key player in the B2B online gaming sector.

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics aimed at addressing unmet medical needs in central nervous system disorders and other rare conditions. The company's lead programs include SLS-002, an intranasal formulation of racemic ketamine designed to treat acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for Parkinson's disease. Additionally, Seelos has several preclinical programs, such as SLS-007, an anti-alpha-synuclein peptidic inhibitor targeting Parkinson's; SLS-008, an antagonist for chronic inflammation in asthma; SLS-010, an oral treatment for narcolepsy; and SLS-012, an injectable therapy for post-operative pain management. Founded in 2016 and headquartered in New York, Seelos aims to improve patient outcomes in both psychiatric and movement disorders, including orphan diseases.

Appili Therapeutics Inc. is a biopharmaceutical company based in Halifax, Canada, focused on developing and commercializing innovative treatments for infectious diseases. Founded in 2015, the company addresses unmet medical needs by advancing a diverse portfolio of anti-infective therapies. This includes Favipiravir, aimed at treating pandemic influenza and COVID-19, as well as ATI-2307, an antifungal candidate in clinical trials for cryptococcal meningitis and invasive candidiasis. Additionally, Appili is developing ATI-1501, a taste-masked oral formulation of metronidazole, and ATI-1503, targeting gram-negative bacteria. The company also works on ATI-1701, a live-attenuated vaccine for Francisella tularensis, illustrating its commitment to improving patient outcomes in the face of serious infections.

Magnis Energy Technologies is an Australian company focused on the exploration and development of mineral properties, particularly natural flake graphite, which is essential for lithium-ion battery production. The company wholly owns the Nachu graphite project in southeast Tanzania, known for its high-quality graphite that meets the growing demand for anode materials in battery technology. Magnis collaborates with C4V, a technical partner responsible for patented battery materials, and holds a minority stake in the company. This partnership enables Magnis to license exclusive anode processing technology aimed at producing high-performance anode materials using ultra-high purity graphite sourced from its Nachu project. Founded in 2005 and headquartered in Sydney, Magnis Energy Technologies has evolved from its former name, emphasizing its commitment to advancing battery technology and supporting electric mobility and energy storage solutions.

Bioasis Technologies Inc. is a biopharmaceutical company focused on the research and development of innovative products for diagnosing and treating neurological diseases and disorders. The company's primary advancement is the xB3 platform, a proprietary technology designed to facilitate the delivery of therapeutics across the blood-brain barrier, which is critical for addressing central nervous system disorders such as brain cancers and neurodegenerative diseases. Bioasis's in-house development initiatives aim to create both symptomatic and disease-modifying treatments, specifically targeting conditions like brain metastases and glioblastoma. Founded in 2007 and headquartered in Guilford, Connecticut, Bioasis Technologies is committed to addressing areas of significant unmet medical need in the field of neurology.

COMSovereign is a pure-play enabler of 5G connectivity and data transmission systems. The company has assembled a portfolio of industry-leading, disruptive, communications, and power technologies as well as niche companies capable of rapid integration and expansion. It focuses on businesses or products to which it can apply new and unique spectral efficiency capabilities including signal modulations, antenna, software, hardware, and firmware technologies. COMSovereign enables connectivity across the entire data transmission spectrum.

Boxlight is an education technology company focused on providing innovative solutions to enhance learning experiences in classrooms. The company develops, sells, and services a comprehensive suite of interactive technologies, including flat panel displays, LED video walls, classroom audio systems, and media players. Additionally, Boxlight offers digital signage and a range of peripherals to support educational environments. Beyond the education sector, the company also caters to corporate and government clients. Boxlight is committed to improving student engagement and outcomes by delivering integrated solutions that encompass software, professional development, and ongoing support services. Furthermore, the company distributes STEM products, such as 3D printing and robotics solutions, to enrich educational offerings.

Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy. At one level, Veyonda® enhances the cancer-killing effect of standard chemotherapy and radiotherapy, thereby enabling lower doses of these toxic therapies to be used.

Avalon Advanced Materials is a mineral exploration and development company that specializes in critical metals and minerals essential for emerging technologies. The company focuses on a range of rare metals and minerals, including lithium, tantalum, niobium, cesium, indium, gallium, germanium, rare earth elements, yttrium, and zirconium, which are increasingly in demand. Avalon is engaged in various projects, notably East Kemptville, Lilypad, Nechalacho, Separation Rapids, and Warren Township, which are aimed at advancing the extraction and processing of these valuable resources.

Vamp is an influencer marketing and content creation platform that links brands to a vetted community of creators, facilitating effective marketing campaigns. Established in Australia in 2015, Vamp has expanded its reach globally, executing campaigns in 65 countries and maintaining teams in major cities such as Sydney, Hong Kong, Singapore, Dubai, London, Jakarta, and Tokyo. The platform offers brands an omni-channel, self-serve solution for engaging with customers on social media. Through partnerships with major platforms like Facebook, TikTok, and YouTube, Vamp enables brands to produce premium, mobile-first content that achieves marketing objectives. This content can be utilized across social feeds, transformed into ad-ready units, or integrated into targeted paid media campaigns, consistently outperforming industry standards. Brands such as Adobe, Estée Lauder, and Nestlé have successfully leveraged Vamp's services to enhance their marketing efforts.

Identitii Limited is a regulatory technology company that develops and licenses enterprise software for banks and money service businesses both in Australia and internationally. Founded in 2014 and based in Woolloomooloo, Australia, the company’s primary product is Overlay+, a digital platform designed to help organizations manage regulatory risk without the need to overhaul existing technology systems. By utilizing tokenization, Identitii connects banks and businesses with essential data to facilitate the processing, reconciliation, and reporting of payments, thereby minimizing delays in the payment process. Additionally, Overlay+ supports ISO 20022 migration, foreign exchange, and AUSTRAC reporting solutions, enabling clients to maintain visibility and control over critical data required for financial crime reporting obligations. While the majority of its operations are in Australia, Identitii also has a presence in Asia and the United States.